REQUEST A DEMO
Total
USD $0.00
Search more companies

Cardiomed S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Health and Personal Care Stores
Full name: Cardiomed S.A. Profile Updated: November 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cardiomed S.A. is an enterprise in Ecuador, with the main office in Guayaquil. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Cardiomed S.A. was incorporated on September 20, 2019. It currently has a total number of 4 (2023) employees. In 2023, the company reported a net sales revenue increase of 68.53%. Its’ total assets recorded a growth of 3.86%. The enterprise’s net profit margin increased by 1.93% in 2023.

Headquarters
Eugenio Almazan 207
Guayaquil; Guayas;

Contact Details: Purchase the Cardiomed S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Cardiomed S.A. report to view the information.
Outstanding Shares:
Purchase the Cardiomed S.A. report to view the information.
Registered Capital:
Purchase the Cardiomed S.A. report to view the information.
Incorporation Date:
September 20, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Cardiomed S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
68.53%
Total operating revenue
68.53%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
76.78%
Total assets
3.86%
Total equity
11.86%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
1.93%
Return on Equity (ROE)
34.4%
Quick Ratio
N/A
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?